Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2009 February;57(1) > Minerva Cardioangiologica 2009 February;57(1):95-101

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

REVIEWS  VASCULAR INTERVENTIONS 2009


Minerva Cardioangiologica 2009 February;57(1):95-101

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Update on the management of atherosclerotic renal artery disease

Fenstad E. R. 1, Kane G. C. 2

1 Mayo Graduate School of Medicine Department of Internal Medicine Mayo Clinic, Rochester, MN, USA 2 Division of Cardiovascular Diseases Department of Internal Medicine Mayo Clinic, Rochester, MN, USA


PDF  


Typically involving the renal artery ostium or proximal segment of the renal artery, atherosclerosis is the major cause of renal artery stenosis. While commonly without direct clinical consequences, the presence of renal artery atherosclerosis is associated with atherosclerotic disease in other vascular beds and in some subjects may give rise to systemic hypertension, progressive renal dysfunction and/or heart failure. Aggressive blood pressure control, atherosclerotic risk factor modification and use of anti-platelet therapy are indicated once diagnosed. The role for concomitant renal artery revascularization remains unclear and the decision should be individualized depending on patient preferences, co-morbidities, institutional expertise, and carefully weighed risks and benefits. Ongoing trials including CORAL and ASTRAL will hopefully provide critical evidence for or against this additive invasive strategy.

top of page

Publication History

Cite this article as

Corresponding author e-mail